Benedikt Westphalen Shares Final ESMO Recommendations for Molecular Tumour Boards
Benedikt Westphalen, Medical Lead of Precision Oncology at CCC München – Comprehensive Cancer Center, shared a post on LinkedIn:
“Now online – the final Open Access version of the ESMO – European Society for Medical Oncology Precision Oncology Working Group Recommendations on the Structure and Quality Indicators for Molecular Tumour Boards in Clinical Practice.
Giuseppe Curigliano and I are deeply grateful for the outstanding support and expertise provided by leading international colleagues in the field. Without their thoughtful input, critical feedback, and collaborative spirit, these first-of-their-kind recommendations would not have been possible.
It has been a privilege to work together in shaping a shared framework for quality-assured precision oncology.”
Title: ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice.
Authors: C.B. Westphalen, L. Boscolo Bielo, P. Aftimos, H. Beltran, M. Benary, D. Chakravarty, M. Collienne, R. Dienstmann, A. El Helali, J. Gainor, P. Horak, C. Le Tourneau, C. Marchiò, C. Massard, F. Meric-Bernstam, C. Pauli, G. Pruneri, F. Roitberg, H.E.G. Russnes, D.B. Solit, N. Starling, V. Subbiah, D. Tamborero, N. Tarazona, C. Turnbull, J. van de Haar, F. André, J. Mateo, G. Curigliano.
Read The Full Article at ESMO Annals of Oncology.
More posts featuring Benedikt Westphalen.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023